medigraphic.com
ISSN 1025-0255 (Electronic)

2019, Number 1

<< Back

AMC 2019; 23 (1)

Bone metastasis: orthopedic point of view

Álvarez-López A, Soto-Carrasco SR, de la Caridad García-Lorenzo Y

Language: Spanish
References: 52
Page: 144-154
PDF size: 775.92 Kb.


ABSTRACT

Background: cancer is a common cause of morbidity-mortality affecting many people internationally and nationally. One way of presentation is bone metastases.
Objective: to deepen the knowledge about the management of patients suffering from bone metastasis from a point of view of the Orthopedics and Traumatology specialties.
Methods: a search of information was carried out in a period of three months (January 1st, 2018 to March 31st, 2018) in the databases PubMed, Hinari, SciELO and Medline through the information locator EndNote by using the words bone metastasis, pathologic fracture, and metastatic bone disease, resulting in a total of 259 articles which 50 of them were selected for the review, 41 of them of the last five years, including ten books.
Development: bone metastasis types were described according to radiographic aspects as: litic, blastic and mix, so like the most common origin sites. The main stages were shown, specially the one related to the risk of pathologic fracture, so that criteria were stated to define treatment. Indication and treatment modalities were described, as well as prognostic factors.
Conclusions: metastatic bone disease is a great challenge for orthopedic surgeon, there are specific indications for surgery and one of the most important aspects to take in mind is the risk of pathologic fracture.


REFERENCES

  1. 1.Nousiainen M, Whyne CM, Yee AJM, Finkel-stein J, Ford M. Surgical management of bone metastases. En: Kardamakis D. Bone metasta-ses, cancer metastasis-biology and treatment. London: Springer; 2009.p.263-86.

  2. 2.Doddala SM, Suryadevara A, Chinta SK, Madisetty AL. Incidence and pattern of bone metastases at presentation in Indian carcino-ma breast patients. Indian J Cancer. 2016 Jul-Sep; 53(3):360-2.

  3. 3.Klaassen Z, Howard LE, de Hoedt A, Amling CL, Aronson WJ, Cooperberg MR, et al. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant pros-tate cancer. Cancer. 2017 May;123(9): 1528-35.

  4. 4.Capanna R, Piccioli A, Di Martino A, Daolio PA, Ippolito V, Maccauro G, et al. Management of long bone metastases: recommendations from the Italian Orthopaedic

  5. Society bone metastasis study group. Expert Rev Anticancer Ther. 2014 Oct;14(10): 1127-34.

  6. 5.Greenbaum SL, Thornhill BA, Geller DS. Characterization and surgical management of

  7. metastatic disease of the tibia. Am J Orthop (Belle Mead NJ).2017 Nov-Dec;46(6):E423-E428.

  8. 6.Guzik G. Oncological and functional results after surgical treatment of bone metastases at the proximal femur. BMC Surg. 2018 Jan; 18(1):5.

  9. 7.Charles T, Ameye L, Gebhart M. Surgical treatment for periacetabular metastatic le-sions. Eur J Surg Oncol. 2017 Sep; 43(9): 1727-32.

  10. 8.Creek AT, Ratner DA, Porter SE. Evaluation and treatment of extremity metastatic disease. In: Peabody TD, Attar S, editors. Orthopaedic Oncology. London: Springer; 2014.p.151-70.

  11. 9.Trujillo-González R, Nieto-Lucio L, Mendoza-Breton JA. Pathological fracture rate due to proximal femur metastasis at a referral hospi-tal. Acta Ortop Mex.2016 Jul-Aug;30(4): 176-80.

  12. 10.Arrigoni F, Bruno F, Zugaro L, Natella R, Cappabianca S, Russo U, et al. Developments in the management of bone metastases with interventional radiology. Acta Biomed.2018 Jan;89(1-S):166-74.

  13. 11.Dwivedi A, Srinivasan A, Kumar S, Trivedi S, Shukla VK, Shukla RC. The longest tumor diameter in one dimension as a predictor for skeletal metastasis in renal cell carcinoma. In-dian J Cancer.2016 Jul-Sep;53(3):420-2.

  14. 12.Heck RK, Toy PC. Malignant tumors of bone. In: Azar FM, Beaty JH, Canale ST, editors. Campbell's Operative Orthopaedics. 13th ed. Philadelphia: Elsevier;2017.p.945-77.

  15. 13.Ameur WB, Belghali S, Akkari I, Zaghouani H, Bouajina E, Jazia EB. Bone metastasis as the first sign of gastric cancer. Pan Afr Med J.2017 Sep;28:95.

  16. 14.Singh G, Sharma D, Goyal S. Primary leio-myosarcoma of breast presenting with metasta-sis: an atypical presentation with dismal prog-nosis. Indian J Med Paediatr Oncol.2017 Oct-Dec;38(4):535-7.

  17. 15.Schirrmeister H, Arlandermir C. Diagnosis of skeletal metastases in malignant extraskeletal cancers. In: Heymann D, editor. Bone Cancer. Philadelphia: Elsevier;2010.p.283-93.

  18. 16.Rajarubendra N, Lawrentschuk N. Imaging of bone metastases. En: Heymann D, editor. Bone Cancer. Philadelphia: Elsevier;2010. p.269-81.

  19. 17.Greenspan A, Jundt G, Remagen W. Differ-ential diagnosis of Orthopaedics Oncology. 2nd ed. Philadelphia:Lippincott Williams & Wil-kins;2007.

  20. 18.Satoh T, Ledesma D, Yoshihara N. The eco-nomic burden of metastatic castration resistant prostate cancer and skeletal related events in Japanese University Hospitals. Asian Pac J Can-cer Prev.2018 Jan;19(1):21-6.

  21. 19.Singh G, Rabbani SA. Bone metastasis. New Jersey: Human Press Inc; 2005.

  22. 20.Harding JJ, Abu-Zeinah G, Chou JF, Owen DH, Ly M, Lowery MA, et al. Frequency, morbid-ity, and mortality of bone metastases in ad-vanced hepatocellular carcinoma. J Natl Compr Canc Netw.2018 Jan;16(1):50-8.

  23. 21.Kardamakis D, Vassiliou V, Chow E. Bone Metastasis: a translational and clinical ap-proach. London: Springer; 2009.

  24. 22.Toy PC, Heck RK Jr. General principles of tumors. In: Azar FM, Beaty JH, Canale ST, edi-tors. Campbell's Operative Orthopaedics. 13th ed. Philadelphia: Elsevier; 2017.p.830-87.

  25. 23.de Keizer B, Krijger GC, Ververs FT, van Es RJJ, de Bree R, Willems S. 68Ga-PSMA PET-CT Imaging of metastatic adenoid cystic carcinoma. Nucl Med Mol Imaging. 2017 Dec;51(4):360-1.

  26. 24.Hwang KE, Oh SJ, Park C, Jeon SJ, Lee JM, Cha BK, et al. Computed tomography morpho-logic features of pulmonary adenocarcinoma with brain/bone metastasis. Korean J Intern Med.2018 Mar;33(2):340-6.

  27. 25.Choi ES, Han I, Cho HS, Park IW, Park JW, Kim HS. Intramedullary nailing for pathological fractures of the proximal humerus. Clin Orthop Surg.2016 Dec;8(4):458-64.

  28. 26.Flais J, Coiffier G, Brillet E, Perdriger A, Gug-genbuhl P. Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott's disease. Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):239-40.

  29. 27.Yamashita S, Katsumi H, Sakane T, Yama-moto A. Bone-targeting dendrimer for the deliv-ery of methotrexate and treatment of bone me-tastasis. J Drug Target.2018 Jan:1-32.

  30. 28.Mirel H. Metastatic disease in long bones. Clin Orthop. 1989 Dec;249:256-64.

  31. 29.Colman MW, Karim SM, Hirsch JA, Yoo AJ, Schwab JH, Hornicek FJ, et al. Percutaneous acetabuloplasty compared with open recon-struction for extensive periacetabular carcinoma metastases. J Arthroplasty.2015 Sep;30(9):1586-91.

  32. 30.Iyer KM. Bone tumors. En: Iyer KM, editors. General Principles of Orhopaedics and Trauma. London: Springer Verlag;2013.p.236-42.

  33. 31.Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metasta-ses in patients with solid tumors: analysis of oncology electronic medical records in the Unit-ed States. BMC Cancer.2018 Jan;18(1):44.

  34. 32.Capanna R, Campanacci DA. The treatment of metastasis in the appendicular skeleton J Bone Joint Surg Br.2001 May;83(4):471-81.

  35. 33.Kang J, Formenti SC. Metastatic osseous pain control: radiation therapy. Semin Inter-vent Radiol.2017 Dec;34(4):322-7.

  36. 34.Kelekis A, Cornelis FH, Tutton S, Filippiadis D. Metastatic osseous pain control: bone abla-tion and cementoplasty. Semin Intervent Radi-ol.2017 Dec;34(4):328-36.

  37. 35.Sprave T, Welte SE, Bruckner T, Förster R, Bostel T, Schlampp I, et al. Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled tri-al. Trials. 2018 Jan;19(1):59.

  38. 36.Arvanius C, Parra JL, Mateo LS, Maroto RG, Borrego AF, Stern LL. Benefits of early in-tramedullary nailing in femoral metastases. Int Orthop. 2014 Jan;38(1):129-32.

  39. 37.Capanna R, De Biase P, Campanacci DA. A new protocol of surgical treatment of long bone metastases. Orthop Traumatol Rehabil. 2003 Jun;5(3):271-5.

  40. 38.Higuchi T, Yamamoto N, Hayashi K, Takeuchi A, Kato S, Miwa S, et al. The efficacy of wide resection for musculoskeletal metastat-ic lesions of renal cell carcinoma. Anticancer Res. 2018 Jan;38(1):577-82.

  41. 39.Ormsby NM, Leong WY, Wong W, Hughes HE, Swaminathan V. The current status of prophylactic femoral intramedullary nailing for metastatic cancer. Ecancer medical sci-ence.2016 Dec; 10:698.

  42. 40.Ross PR, Kolovich GP, Mayerson JL. Har-rington rod revision after failed total hip ar-throplasty due to missed acetabular metasta-sis. Am J Orthop (Belle Mead NJ).2015 Mar;44(3):E75-7.

  43. 41.Shah-Nawaz MD, Savage J, Scharschmidt TJ, Patel A. Evaluation and treatment of spinal metastatic disease. In: Peabody TD, Attar S. Orthopaedic Oncology. London: Spring-er;2014.p.131-50.

  44. 42.Srikanth KP, Srinivas C, Gowrishankarswa-my LG, Chandrasekar C. Endoprosthetic recon-struction for metastatic phaeochromocytoma in the distal femur: a case report. J Clin Orthop Trauma. 2016 Oct-Dec;7(Suppl 1):12-6.

  45. 43.Willeumier JJ, van der Linden YM, van de Sande MAJ, Dijkstra PD. Treatment of patho-logical fractures of the long bones. EFORT Open Rev. 2017 Mar;1(5):136-145.

  46. 44.Laredo JD, Mosseri J, Nizard R. Percutane-ous nailing and cementoplasty for palliative management of supra-acetabular iliac wing metastases: a case report. JBJS Case Connect. 2017 Jul-Sep;7(3):e46.

  47. 45.Lozano-Calderon SA, Kaiser CL, Osler PM, Raskin KA. Cemented total hip arthroplasty with retrograde ischioacetabular steinmann pin reconstruction for periacetabular metastatic carcinoma. J Arthroplasty.2016 Jul;31(7): 1555-60.

  48. 46.de Gori M, D’Arienzo A, Andreani L, Beltrami G, Campanacci DA, De Biase P, et al. Complications and survival of megaprostheses after resection of bone metastases. J Biol Reg-ul Homeost Agents. 2017 Oct-Dec;31(4 suppl 1):43-50.

  49. 47.Wang B, Chen W, Xie X, Tu J, Huang G, Zou C, et al. Development and validation of a prog-nostic index to predict pulmonary metastasis of giant cell tumor of bone. Oncotarget. 2017 Nov;8(64):108054-63.

  50. 48.Forsberg JA, Wedin R, Boland PJ, Healey JH. Can we estimate short- and intermediate-term survival in patients undergoing surgery for metastatic bone disease? Clin Orthop Relat Res. 2017 Apr;475(4):1252-61.

  51. 49.Izumi H, Igishi T, Yamasaki A, Takeda K, Yanai M, Tanaka N, et al. Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases. Mol Clin Oncol. 2017 Dec;7(6):1000-4.

  52. 50.Piccioli A, Spinelli MS, Forsberg JA, Wedin R, Healey JH, Ippolito V, et al. How do we esti-mate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations. BMC Cancer. 2015 May;15:424.




2020     |     www.medigraphic.com